Skip to main content
. Author manuscript; available in PMC: 2013 Dec 9.
Published in final edited form as: Pediatr Diabetes. 2010 Nov;11(7):10.1111/j.1399-5448.2009.00632.x. doi: 10.1111/j.1399-5448.2009.00632.x

Table 2.

Patient characteristics at baseline and 5 years later, mean ± S.E.M. Baseline is the time of the first abnormal glucose tolerance test in CF AGT. CF NGT were matched by gender and baseline age to CF AGT.

At Baseline
Five Year Follow-Up
NGT (n=31) AGT (n=31) P value NGT (n=31) AGT(n=31) P value
Age (years) 8 ± 0 8 ± 0 p = 0.07 13 ± 0 13 ± 0 p = 0.16
Height (cm) 123 ± 1 122 ± 1 p = 0.53 151 ± 1 150 ± 1 p = 0.33
Weight (kg) 25 ± 1 25 ± 1 p = 0.75 43± 1 42 ± 1 p =0.61
BMI percentile 54 ± 4 58 ± 4 p =0.50 49 ± 3 49 ± 3 p =0.98
FEV1 %predicted 107 ± 3 110 ± 3 p =0.53 94 ± 3 100 ± 3 p =0.14
FVC %predicted 110 ± 3 109 ± 3 p =0.91 100 ± 2 102 ± 2 p =0.33

The magnitude of change over the five years for each parameter was also not significantly different for AGT compared to NGT.